Extracellular vesicles (EVs) are lipid bilayer-enclosed particles released by all cell types, ranging in size from 20 nanometers to 10 microns. EVs are categorized into small EVs (sEVs) (<200 nm) and large EVs (lEVs) (>200 nm). Their composition varies depending on their cell of origin and includes proteins, lipids, nucleic acids, metabolites, and organelles. EVs are classified into various subtypes, such as ectosomes, microvesicles, and exosomes, based on their biogenesis. They play diverse biological roles, such as eliminating unwanted materials, transferring proteins and nucleic acids, recycling molecules, signaling, and aiding in cancer metastasis.


In recent years, biomedical research globally and in Taiwan has made significant strides, particularly in developing and applying EVs technology since EVs involved in aging, inflammation, coagulation, disease progression, T cell longevity, and serve as potential biomarkers. Modern biomedical research demands interdisciplinary collaboration and knowledge sharing, with close interaction between different fields now essential for advancing exosome research and its applications. At the upcoming International Forum of Extracellular Vesicles Technology and Novel Therapeutics, participants will explore the latest advancements in exosome technology and its applications in various diseases, driving forward scientific progress in this field.